Mandolin

Closed

Precision automation for specialty drugs

Indianapolis, United States · Founded 2020

Founded
2020
Business Model
B2B
Last Round
Series AJun 2025
Rounds
1

About

Mandolin provides precision automation for specialty drugs, replacing fragmented manual workflows with AI agents that execute the end-to-end administrative lifecycle for specialty drug administration. The platform automates intake and onboarding, benefits verification, patient out-of-pocket estimation, medical policy review, prior authorizations, claims statusing, and appeal automation — all without traditional API integrations. Designed for specialty pharmacies, infusion centers, and specialty clinics, Mandolin enables healthcare providers to increase throughput and revenue without adding headcount, while maintaining full compliance and audit trails.

Summary

Mandolin is an Artificial Intelligence company based in Indianapolis, United States, founded in 2020. Its most recent funding was a Series A round in Jun 2025. Investors include Greylock Partners, SignalFire and SV Angel.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AJun 2025

Investors

Similar Companies